Ilaria Stura

Dr. Ilaria Stura

Neurosciences, Università degli Studi di Torino, Turin, Piedmont, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2019 in Materials
Verified
Journal Article
Open access
PDF file
SAShoeb Anwar Ansari
Shoeb Anwar Ansari
EFEleonora Ficiarà
Eleonora Ficiarà
FRFederico Alessandro Ruffinatti
Federico Alessandro Ruffinatti
ISIlaria Stura
Ilaria Stura
Monica ArgenzianoMonica Argenziano
Monica Argenziano
Federico D'AgataFederico D'Agata
Federico D'Agata
Magnetic Nanoparticles (MNPs) are of great interest in biomedicine, due to their wide range of applications. During recent years, one of the most challenging goals is the development of new strategies to finely tune the unique properties of MNPs, in order to improve their effectiveness in the biomedical field. This review provides an up-to-date overview of the methods of synthesis and functionalization of MNPs focusing on Iron Oxide Nanoparticles (IONPs). Firstly, synthesis strategies for fabricating IONPs of different composition, sizes, shapes, and structures are outlined. We describe the close link between physicochemical properties and magnetic characterization, essential to developing innovative and powerful magnetic-driven nanocarriers. In conclusion, we provide a complete background of IONPs functionalization, safety, and applications for the treatment of Central Nervous System disorders.

21 December 2017 in Molecules
Verified
Journal Article
Open access
PDF file
Federico D'AgataFederico D'Agata
Federico D'Agata
FRFederico Alessandro Ruffinatti
Federico Alessandro Ruffinatti
SBSilvia Boschi
Silvia Boschi
ISIlaria Stura
Ilaria Stura
IRInnocenzo Rainero
Innocenzo Rainero
CGCaterina Guiot
Caterina Guiot
One of the most challenging goals in pharmacological research is overcoming the Blood Brain Barrier (BBB) to deliver drugs to the Central Nervous System (CNS). The use of physical means, such as steady and alternating magnetic fields to drive nanocarriers with proper magnetic characteristics may prove to be a useful strategy. The present review aims at providing an up-to-date picture of the applications of magnetic-driven nanotheranostics agents to the CNS. Although well consolidated on physical ground, some of the techniques described herein are still under investigation on in vitro or in silico models, while others have already entered in—or are close to—clinical validation. The review provides a concise overview of the physical principles underlying the behavior of magnetic nanoparticles (MNPs) interacting with an external magnetic field. Thereafter we describe the physiological pathways by which a substance can reach the brain from the bloodstream and then we focus on those MNP applications that aim at a nondestructive crossing of the BBB such as static magnetic fields to facilitate the passage of drugs and alternating magnetic fields to increment BBB permeability by magnetic heating. In conclusion, we briefly cite the most notable biomedical applications of MNPs and some relevant remarks about their safety and potential toxicity.

Verified
Journal Article
Open access
PDF file
EFEleonora Ficiarà
Eleonora Ficiarà
ISIlaria Stura
Ilaria Stura
CGCaterina Guiot
Caterina Guiot
The alteration of iron homeostasis related to the aging process is responsible for increased iron levels, potentially leading to oxidative cellular damage. Iron is modulated in the Central Nervous System in a very sensitive manner and an abnormal accumulation of iron in the brain has been proposed as a biomarker of neurodegeneration. However, contrasting results have been presented regarding brain iron accumulation and the potential link with other factors during aging and neurodegeneration. Such uncertainties partly depend on the fact that different techniques can be used to estimate the distribution of iron in the brain, e.g., indirect (e.g., MRI) or direct (post-mortem estimation) approaches. Furthermore, recent evidence suggests that the propensity of brain cells to accumulate excessive iron as a function of aging largely depends on their anatomical location. This review aims to collect the available data on the association between iron concentration in the brain and aging, shedding light on potential mechanisms that may be helpful in the detection of physiological neurodegeneration processes and neurodegenerative diseases such as Alzheimer’s disease.

13 March 2019 in Nanotechnology
Verified
Journal Article
Closed access
PDF file
FBFederica Bessone
Federica Bessone
Monica ArgenzianoMonica Argenziano
Monica Argenziano
Giorgio GrilloGiorgio Grillo
Giorgio Grillo
BFBenedetta Ferrara
Benedetta Ferrara
SPStefania Pizzimenti
Stefania Pizzimenti
CDChiara Dianzani
Chiara Dianzani
Preventing recurrences and metastasis of prostate cancer after prostatectomy by administering adjuvant therapies is quite a controversial issue. In addition to effectiveness, absence of side effects and long term toxicity are mandatory. Curcuminoids (Curc) extracted with innovative techniques and effectively loaded by polymeric nanobubbles (Curc-NBs) satisfy such requirements. Curc-NBs showed stable over 30 d, were effectively internalized by tumor cells and were able to slowly release Curc in a sustained way. Significant biological effects were detected in PC-3 and DU-145 cell lines where Curc-NBs were able to inhibit adhesion and migration, to promote cell apoptosis and to affect cell viability and colony-forming capacity in a dose-dependent manner. Since the favourable effects are already detectable at very low doses, which can be reached at a clinical level, the actual drug concentration can be visualized and monitored by US or MRI, Curc-NBs can be proposed as an effective adjuvant theranostic tool.

15 August 2015 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
DGD. Gabriele
D. Gabriele
DCD. Collura
D. Collura
MOMarco Oderda
Marco Oderda
ISIlaria Stura
Ilaria Stura
CFC. Fiorito
C. Fiorito
PGP. Gabriele
P. Gabriele

26 February 2018 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
AKAmina Khadjavi
Amina Khadjavi
ISIlaria Stura
Ilaria Stura
MPMauro Prato
Mauro Prato
VMValerio Giacomo Minero
Valerio Giacomo Minero
APAlice Panariti
Alice Panariti
CGCaterina Guiot
Caterina Guiot